Navigation Links
MINRAD International, Inc. Announces 2007 Financial Results
Date:3/31/2008

ceivable 3,310 10,473

License agreement receivable 1,000 -

Inventories, net 12,402 4,360

Prepaid expenses and other 1,121 1,563

Total current assets 18,071 28,309

Property and equipment:

Machinery and equipment 15,169 2,420

Computer equipment and software 1,471 571

Furniture and fixtures 815 662

Leasehold improvements 385 385

Construction in progress 7,692 4,177

25,532 8,215

Less accumulated depreciation 2,247 1,234

Net property and equipment 23,285 6,981

Other assets, net 639 439

$ 41,995 $ 35,729

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Demand notes payable $ 6,000 $ -

Accounts payable 12,983 965

Accrued expenses 1,004 1,262

Current portion of long term debt 206 -

Current portion of deferred income 103 -

Total current liabilities 20,296 2,227

Long-term liabilities

Long-term debt 1,725 -

Long-term deferred income 897 -

Total long-term liabilities
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
5. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
6. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
7. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
8. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
9. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
10. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
11. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Cosmetic Bootcamp University New York Deemed A Huge Success 59289 1Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 1Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 2Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 3Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 1Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 2Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 3